Atlas Trials

Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study

Clinical trial NCT04982471 · TERMINATED

Trial details

NCT number
NCT04982471
Sponsor
Celgene
Status
TERMINATED
Study type
OBSERVATIONAL
Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Follicular
Start date
2021-11-03
Primary completion
2023-08-03
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.